Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation

Oxidative stress and neuroinflammation contribute significantly to the development and progression of diabetic retinopathy. Fenofibrate has received great attention as it benefits diabetic patients by reducing retinal laser requirement. Nuclear factor erythroid-2-related factor 2 (Nrf2) is a master...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Molecular and cellular biochemistry Ročník 445; číslo 1-2; s. 105 - 115
Hlavní autori: Liu, Qiuping, Zhang, Fengjun, Zhang, Xian, Cheng, Rui, Ma, Jian-xing, Yi, Jinglin, Li, Jingming
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: New York Springer US 01.08.2018
Springer
Springer Nature B.V
Predmet:
ISSN:0300-8177, 1573-4919, 1573-4919
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Oxidative stress and neuroinflammation contribute significantly to the development and progression of diabetic retinopathy. Fenofibrate has received great attention as it benefits diabetic patients by reducing retinal laser requirement. Nuclear factor erythroid-2-related factor 2 (Nrf2) is a master regulator of anti-oxidative defense. Activation of nucleotide binding domain, leucine-rich repeat-containing receptor (NLR), pyrin domain-containing 3 (NLRP3) inflammasome plays a pivotal role in neuroinflammation. The purpose of this study is to determine whether fenofibrate protects retinas from oxidative damage and neuroinflammation via modulating the Nrf2 pathway and blocking NLRP3 inflammasome activation during diabetes. Diabetes is induced by intraperitoneal injection of streptozotocin in mice. Fenofibrate was given to mice in rodent chow. Upregulation of Nrf2 and NLRP3 inflammasome, enhanced ROS formation, and increased leukostasis and vascular leakage were observed in diabetic mouse retinas. Notably, Nrf2 and Caspase-1 were mainly colocalized with glutamine synthetase, one of the Mȕller cell markers. Fenofibrate further increased the expression of Nrf2 and its target gene NQO-1 and HO-1 and reduced ROS formation in diabetic retinas. In addition, retinal expression of NLRP3, Caspase-1 p20, IL-1β p17, and ICAM-1 were dramatically increased in vehicle-treated diabetic mice, which were abolished by fenofibrate intervention. Moreover, fenofibrate treatment also attenuated diabetes-induced retinal leukostasis and vascular leakage in mice. Taken together, fenofibrate attenuates oxidative stress and neuroinflammation in diabetic retinas, which is at least partially through modulating Nrf2 expression and NLRP3 inflammasome activation.
AbstractList Oxidative stress and neuroinflammation contribute significantly to the development and progression of diabetic retinopathy. Fenofibrate has received great attention as it benefits diabetic patients by reducing retinal laser requirement. Nuclear factor erythroid-2-related factor 2 (Nrf2) is a master regulator of anti-oxidative defense. Activation of nucleotide binding domain, leucine-rich repeat-containing receptor (NLR), pyrin domain-containing 3 (NLRP3) inflammasome plays a pivotal role in neuroinflammation. The purpose of this study is to determine whether fenofibrate protects retinas from oxidative damage and neuroinflammation via modulating the Nrf2 pathway and blocking NLRP3 inflammasome activation during diabetes. Diabetes is induced by intraperitoneal injection of streptozotocin in mice. Fenofibrate was given to mice in rodent chow. Upregulation of Nrf2 and NLRP3 inflammasome, enhanced ROS formation, and increased leukostasis and vascular leakage were observed in diabetic mouse retinas. Notably, Nrf2 and Caspase-1 were mainly colocalized with glutamine synthetase, one of the Mȕller cell markers. Fenofibrate further increased the expression of Nrf2 and its target gene NQO-1 and HO-1 and reduced ROS formation in diabetic retinas. In addition, retinal expression of NLRP3, Caspase-1 p20, IL-1β p17, and ICAM-1 were dramatically increased in vehicle-treated diabetic mice, which were abolished by fenofibrate intervention. Moreover, fenofibrate treatment also attenuated diabetes-induced retinal leukostasis and vascular leakage in mice. Taken together, fenofibrate attenuates oxidative stress and neuroinflammation in diabetic retinas, which is at least partially through modulating Nrf2 expression and NLRP3 inflammasome activation.
Oxidative stress and neuroinflammation contribute significantly to the development and progression of diabetic retinopathy. Fenofibrate has received great attention as it benefits diabetic patients by reducing retinal laser requirement. Nuclear factor erythroid-2-related factor 2 (Nrf2) is a master regulator of anti-oxidative defense. Activation of nucleotide binding domain, leucine-rich repeat-containing receptor (NLR), pyrin domain-containing 3 (NLRP3) inflammasome plays a pivotal role in neuroinflammation. The purpose of this study is to determine whether fenofibrate protects retinas from oxidative damage and neuroinflammation via modulating the Nrf2 pathway and blocking NLRP3 inflammasome activation during diabetes. Diabetes is induced by intraperitoneal injection of streptozotocin in mice. Fenofibrate was given to mice in rodent chow. Upregulation of Nrf2 and NLRP3 inflammasome, enhanced ROS formation, and increased leukostasis and vascular leakage were observed in diabetic mouse retinas. Notably, Nrf2 and Caspase-1 were mainly colocalized with glutamine synthetase, one of the MÈller cell markers. Fenofibrate further increased the expression of Nrf2 and its target gene NQO-1 and HO-1 and reduced ROS formation in diabetic retinas. In addition, retinal expression of NLRP3, Caspase-1 p20, IL-1[beta] p17, and ICAM-1 were dramatically increased in vehicle-treated diabetic mice, which were abolished by fenofibrate intervention. Moreover, fenofibrate treatment also attenuated diabetes-induced retinal leukostasis and vascular leakage in mice. Taken together, fenofibrate attenuates oxidative stress and neuroinflammation in diabetic retinas, which is at least partially through modulating Nrf2 expression and NLRP3 inflammasome activation.
Oxidative stress and neuroinflammation contribute significantly to the development and progression of diabetic retinopathy. Fenofibrate has received great attention as it benefits diabetic patients by reducing retinal laser requirement. Nuclear factor erythroid-2-related factor 2 (Nrf2) is a master regulator of anti-oxidative defense. Activation of nucleotide binding domain, leucine-rich repeat-containing receptor (NLR), pyrin domain-containing 3 (NLRP3) inflammasome plays a pivotal role in neuroinflammation. The purpose of this study is to determine whether fenofibrate protects retinas from oxidative damage and neuroinflammation via modulating the Nrf2 pathway and blocking NLRP3 inflammasome activation during diabetes. Diabetes is induced by intraperitoneal injection of streptozotocin in mice. Fenofibrate was given to mice in rodent chow. Upregulation of Nrf2 and NLRP3 inflammasome, enhanced ROS formation, and increased leukostasis and vascular leakage were observed in diabetic mouse retinas. Notably, Nrf2 and Caspase-1 were mainly colocalized with glutamine synthetase, one of the Mȕller cell markers. Fenofibrate further increased the expression of Nrf2 and its target gene NQO-1 and HO-1 and reduced ROS formation in diabetic retinas. In addition, retinal expression of NLRP3, Caspase-1 p20, IL-1β p17, and ICAM-1 were dramatically increased in vehicle-treated diabetic mice, which were abolished by fenofibrate intervention. Moreover, fenofibrate treatment also attenuated diabetes-induced retinal leukostasis and vascular leakage in mice. Taken together, fenofibrate attenuates oxidative stress and neuroinflammation in diabetic retinas, which is at least partially through modulating Nrf2 expression and NLRP3 inflammasome activation.Oxidative stress and neuroinflammation contribute significantly to the development and progression of diabetic retinopathy. Fenofibrate has received great attention as it benefits diabetic patients by reducing retinal laser requirement. Nuclear factor erythroid-2-related factor 2 (Nrf2) is a master regulator of anti-oxidative defense. Activation of nucleotide binding domain, leucine-rich repeat-containing receptor (NLR), pyrin domain-containing 3 (NLRP3) inflammasome plays a pivotal role in neuroinflammation. The purpose of this study is to determine whether fenofibrate protects retinas from oxidative damage and neuroinflammation via modulating the Nrf2 pathway and blocking NLRP3 inflammasome activation during diabetes. Diabetes is induced by intraperitoneal injection of streptozotocin in mice. Fenofibrate was given to mice in rodent chow. Upregulation of Nrf2 and NLRP3 inflammasome, enhanced ROS formation, and increased leukostasis and vascular leakage were observed in diabetic mouse retinas. Notably, Nrf2 and Caspase-1 were mainly colocalized with glutamine synthetase, one of the Mȕller cell markers. Fenofibrate further increased the expression of Nrf2 and its target gene NQO-1 and HO-1 and reduced ROS formation in diabetic retinas. In addition, retinal expression of NLRP3, Caspase-1 p20, IL-1β p17, and ICAM-1 were dramatically increased in vehicle-treated diabetic mice, which were abolished by fenofibrate intervention. Moreover, fenofibrate treatment also attenuated diabetes-induced retinal leukostasis and vascular leakage in mice. Taken together, fenofibrate attenuates oxidative stress and neuroinflammation in diabetic retinas, which is at least partially through modulating Nrf2 expression and NLRP3 inflammasome activation.
Audience Academic
Author Zhang, Xian
Cheng, Rui
Zhang, Fengjun
Yi, Jinglin
Liu, Qiuping
Li, Jingming
Ma, Jian-xing
Author_xml – sequence: 1
  givenname: Qiuping
  surname: Liu
  fullname: Liu, Qiuping
  organization: Department of Ophthalmology, Affiliated Eye Hospital of Nanchang University
– sequence: 2
  givenname: Fengjun
  surname: Zhang
  fullname: Zhang, Fengjun
  organization: Department of Ophthalmology, Affiliated Eye Hospital of Nanchang University
– sequence: 3
  givenname: Xian
  surname: Zhang
  fullname: Zhang, Xian
  organization: Department of Ophthalmology, Affiliated Eye Hospital of Nanchang University
– sequence: 4
  givenname: Rui
  surname: Cheng
  fullname: Cheng, Rui
  organization: Department of Physiology, Health Sciences Center, University of Oklahoma
– sequence: 5
  givenname: Jian-xing
  surname: Ma
  fullname: Ma, Jian-xing
  organization: Department of Physiology, Health Sciences Center, University of Oklahoma
– sequence: 6
  givenname: Jinglin
  surname: Yi
  fullname: Yi, Jinglin
  email: yjl0791@126.com
  organization: Department of Ophthalmology, Affiliated Eye Hospital of Nanchang University
– sequence: 7
  givenname: Jingming
  orcidid: 0000-0003-2300-8614
  surname: Li
  fullname: Li, Jingming
  email: jingming_li@126.com
  organization: Department of Ophthalmology, Affiliated Eye Hospital of Nanchang University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29264825$$D View this record in MEDLINE/PubMed
BookMark eNp9kl1rFDEUhoNU7Lb6A7yRAW-8mZozSSaZy1JaFZa2FL0OmcyZNXUmWZMZ6f57M24LtVQJ5OPwvG84H0fkwAePhLwFegKUyo8JgAItKciSVaIu716QFQjJSt5Ac0BWlFFaKpDykByldEszTAFekcOqqWquKrEiPy7Qh9610UxYmBEHF5ZrKjpnWpycLWLefdia6fuuaHfFGLp5MDm0KS5jXxXJbbwZlqfxXXG5vrlmhfP9YMbRpDBmUzu5X1kQ_GvysjdDwjf35zH5dnH-9exzub769OXsdF1aQcVUMonAu17J1nDsKFMt0r5vEUTDha1MTZnlQLm1TS2kZFK2iqtWWa4MoLLsmHzY-25j-DljmvToksVhMB7DnDQ0suENr-omo--foLdhjjmhhVJUAqvFI2pjBtQ5uzBFYxdTfSq44LKmqs7UyTNUXh2OzubO9S7H_xK8u_98bkfs9Da60cSdfuhOBuQesDGkFLHX1k1_Spmd3aCB6mUO9H4OdJ4DvcyBvstKeKJ8MP-fptprUmb9BuOjWvxT9BsTj8Oh
CitedBy_id crossref_primary_10_3389_fphys_2018_01268
crossref_primary_10_1002_jbt_22568
crossref_primary_10_1002_med_21711
crossref_primary_10_2147_DMSO_S264215
crossref_primary_10_1167_iovs_63_3_3
crossref_primary_10_1007_s11064_023_03981_1
crossref_primary_10_1016_j_biopha_2025_118106
crossref_primary_10_3390_antiox13050594
crossref_primary_10_1080_02713683_2019_1632350
crossref_primary_10_3389_fendo_2021_630536
crossref_primary_10_3389_fphar_2022_953691
crossref_primary_10_1007_s00011_022_01615_w
crossref_primary_10_3389_fphar_2021_796565
crossref_primary_10_1016_j_exer_2020_108065
crossref_primary_10_1007_s12035_024_04105_8
crossref_primary_10_3390_jcm12186022
crossref_primary_10_1007_s00125_019_4959_1
crossref_primary_10_1016_j_phymed_2025_156430
crossref_primary_10_3389_fendo_2024_1347864
crossref_primary_10_3390_ijms25031610
crossref_primary_10_3390_jcm10010126
crossref_primary_10_1016_j_phyplu_2025_100841
crossref_primary_10_3390_ijtm4030027
crossref_primary_10_1016_j_mvr_2021_104265
crossref_primary_10_3390_ijms21030899
crossref_primary_10_1186_s13287_024_03654_y
crossref_primary_10_1007_s43440_020_00096_0
crossref_primary_10_3389_fnmol_2022_847440
crossref_primary_10_1016_j_exer_2020_108255
crossref_primary_10_3389_fnins_2019_01172
crossref_primary_10_3389_fmicb_2023_1256878
crossref_primary_10_3390_jcm10204666
crossref_primary_10_1016_j_lfs_2019_117138
crossref_primary_10_1016_j_lfs_2019_116962
crossref_primary_10_2337_db21_0853
crossref_primary_10_3389_fendo_2025_1501305
crossref_primary_10_4081_ejh_2022_3412
crossref_primary_10_2147_JIR_S336148
crossref_primary_10_1016_j_lfs_2023_122228
crossref_primary_10_3389_fbioe_2022_913791
crossref_primary_10_1155_2020_9410952
crossref_primary_10_4251_wjgo_v17_i2_100094
crossref_primary_10_1016_j_jdiacomp_2025_109135
crossref_primary_10_3390_antiox9080729
crossref_primary_10_1155_2019_8458472
crossref_primary_10_1007_s00125_022_05655_z
crossref_primary_10_1080_09273948_2020_1811350
crossref_primary_10_1016_j_exer_2020_108003
crossref_primary_10_1155_2022_7836828
crossref_primary_10_2147_DDDT_S490772
crossref_primary_10_3390_metabo14070388
crossref_primary_10_1016_j_ejphar_2023_176241
crossref_primary_10_1186_s40001_024_01700_2
crossref_primary_10_3389_fimmu_2023_1052756
crossref_primary_10_1167_iovs_65_3_34
crossref_primary_10_1124_dmd_123_001365
crossref_primary_10_2337_dbi22_0037
crossref_primary_10_1002_ddr_21579
crossref_primary_10_1016_j_preteyeres_2022_101151
crossref_primary_10_1155_2020_3096470
crossref_primary_10_1016_j_ejmech_2022_114829
crossref_primary_10_1016_j_bcp_2023_115569
crossref_primary_10_3390_cells9081812
crossref_primary_10_3389_fcvm_2022_985020
crossref_primary_10_1016_j_ejmech_2023_115336
crossref_primary_10_1007_s11033_020_06032_y
crossref_primary_10_1007_s12272_023_01439_0
crossref_primary_10_3390_antiox11040617
Cites_doi 10.1073/pnas.1512683112
10.1016/j.bbrc.2015.08.056
10.2337/db11-0413
10.1016/S0140-6736(07)61607-9
10.1056/NEJMoa1001288
10.1073/pnas.1314575110
10.1016/j.cell.2006.08.002
10.1016/j.freeradbiomed.2016.02.002
10.1038/ki.2012.439
10.1074/jbc.M110.199729
10.1007/s00011-016-1002-6
10.1097/FJC.0b013e31826216ed
10.1111/aos.13427
10.1016/S0074-7696(03)30005-1
10.1038/nature05485
10.1016/j.preteyeres.2006.05.003
10.1016/j.freeradbiomed.2016.08.013
10.1007/s00125-013-3093-8
10.1152/ajpheart.00005.2016
10.3892/etm.2016.3033
10.1111/jnc.14029
10.1038/s41598-017-01994-9
10.1167/iovs.17-22250
10.1002/glia.22942
10.1016/j.exer.2016.12.001
10.1016/j.visres.2017.05.005
10.2337/db11-0315
10.2337/db16-0426
10.1016/j.lfs.2016.08.001
10.2337/db13-0800
10.1038/ni.1831
10.2337/db09-1057
10.1016/j.ajpath.2014.06.021
10.2337/diabetes.54.6.1615
10.1159/000479999
10.1097/00004397-198702740-00004
ContentType Journal Article
Copyright Springer Science+Business Media, LLC, part of Springer Nature 2017
COPYRIGHT 2018 Springer
Molecular and Cellular Biochemistry is a copyright of Springer, (2017). All Rights Reserved.
Copyright_xml – notice: Springer Science+Business Media, LLC, part of Springer Nature 2017
– notice: COPYRIGHT 2018 Springer
– notice: Molecular and Cellular Biochemistry is a copyright of Springer, (2017). All Rights Reserved.
DBID AAYXX
CITATION
NPM
3V.
7QL
7QP
7T5
7T7
7TK
7TM
7TO
7U9
7X7
7XB
88A
88E
88I
8AO
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7N
M7P
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
RC3
7X8
DOI 10.1007/s11010-017-3256-x
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Science Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Central Basic
ProQuest Science Journals
ProQuest SciTech Collection
ProQuest Medical Library
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

ProQuest Central Student
MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1573-4919
EndPage 115
ExternalDocumentID A545476086
29264825
10_1007_s11010_017_3256_x
Genre Journal Article
GrantInformation_xml – fundername: NSFC
  grantid: 81400427; 81460163; 81300786
– fundername: Young Talent Scholar Grant
  grantid: 2016KJXX-12
– fundername: FRFCU Grant
  grantid: xjj2015015
– fundername: Research Grants from Jiangxi Education Department
  grantid: GJJ14094; GJJ13175
– fundername: RFDP grant
  grantid: 20133601120012
– fundername: Research Grants from Jiangxi Science and Technology Department
  grantid: 20142BDH80005, 20132BAB205024; 20142BAB215029
– fundername: NSFC
  grantid: 81460163
– fundername: Research Grants from Jiangxi Science and Technology Department
  grantid: 20142BDH80005, 20132BAB205024
– fundername: Research Grants from Jiangxi Science and Technology Department
  grantid: 20142BAB215029
– fundername: NSFC
  grantid: 81300786
– fundername: Research Grants from Jiangxi Education Department
  grantid: GJJ14094
– fundername: Research Grants from Jiangxi Education Department
  grantid: GJJ13175
– fundername: NSFC
  grantid: 81400427
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
-~X
.55
.86
.GJ
.VR
06C
06D
0R~
0VY
123
199
1N0
1SB
2.D
203
28-
29M
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3SX
3V.
4.4
406
408
409
40D
40E
53G
5QI
5RE
5VS
67N
67Z
6NX
78A
7X7
88A
88E
88I
8AO
8CJ
8FE
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
A8Z
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACGOD
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACREN
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADYPR
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEUYN
AEVLU
AEXYK
AFBBN
AFEXP
AFFNX
AFGCZ
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBNVY
BBWZM
BDATZ
BENPR
BGNMA
BHPHI
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
D1J
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAG
IAO
IH2
IHE
IHR
IJ-
IKXTQ
INH
INR
ITC
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAK
LK8
LLZTM
M0L
M1P
M2P
M4Y
M7P
MA-
MVM
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
TUS
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WH7
WIP
WJK
WK6
WK8
X7M
YLTOR
Z45
Z7U
Z7V
Z7W
Z82
Z83
Z87
Z8O
Z8P
Z8Q
Z8V
Z8W
Z91
ZGI
ZMTXR
ZOVNA
~EX
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
ADHKG
AEZWR
AFDZB
AFFHD
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
NPM
7QL
7QP
7T5
7T7
7TK
7TM
7TO
7U9
7XB
8FD
8FK
C1K
ESTFP
FR3
H94
K9.
M7N
P64
PKEHL
PQEST
PQUKI
PRINS
Q9U
RC3
7X8
PUEGO
ID FETCH-LOGICAL-c505t-37e14df87ba4ed038be0ffbe15945c2a603c4104cc96577377b848b8c48a1e8c3
IEDL.DBID RSV
ISICitedReferencesCount 81
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000437464800011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0300-8177
1573-4919
IngestDate Fri Sep 05 06:04:12 EDT 2025
Tue Nov 04 22:09:14 EST 2025
Sat Nov 29 13:39:30 EST 2025
Sat Nov 29 09:54:31 EST 2025
Thu Apr 03 07:01:44 EDT 2025
Tue Nov 18 22:52:09 EST 2025
Sat Nov 29 03:30:53 EST 2025
Fri Feb 21 02:32:22 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1-2
Keywords Fenofibrate
Diabetic retinopathy
Oxidative stress
Inflammasome
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c505t-37e14df87ba4ed038be0ffbe15945c2a603c4104cc96577377b848b8c48a1e8c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-2300-8614
PMID 29264825
PQID 1980713659
PQPubID 54196
PageCount 11
ParticipantIDs proquest_miscellaneous_1979494269
proquest_journals_1980713659
gale_infotracmisc_A545476086
gale_infotracacademiconefile_A545476086
pubmed_primary_29264825
crossref_citationtrail_10_1007_s11010_017_3256_x
crossref_primary_10_1007_s11010_017_3256_x
springer_journals_10_1007_s11010_017_3256_x
PublicationCentury 2000
PublicationDate 2018-08-01
PublicationDateYYYYMMDD 2018-08-01
PublicationDate_xml – month: 08
  year: 2018
  text: 2018-08-01
  day: 01
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: Netherlands
PublicationSubtitle An International Journal for Chemical Biology in Health and Disease
PublicationTitle Molecular and cellular biochemistry
PublicationTitleAbbrev Mol Cell Biochem
PublicationTitleAlternate Mol Cell Biochem
PublicationYear 2018
Publisher Springer US
Springer
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer
– name: Springer Nature B.V
References Chen, Zhao, Zhao, Lu, Ni, Zou, Lu, Xu, Guan, Zheng, Qiu (CR35) 2017; 66
Inoue, Shimazawa, Noda, Nagano, Otsuka, Kuse, Nakano, Tsuruma, Nakagami, Hara (CR25) 2017; 141
Cheng, Zhang, Guo, Li, Sun, Chen, Zhang, Lu, Tan, Feng, Fu, Liu, Xu, Cai (CR5) 2016; 93
Sun, Xiu, Liu, Tao, Wang, Qu (CR26) 2016; 11
Zhou, Tardivel, Thorens, Choi, Tschopp (CR10) 2010; 11
Zhong, Li, Chen, Wang, Ratan, Zhang (CR13) 2012; 61
Eastlake, Banerjee, Angbohang, Charteris, Khaw, Limb (CR37) 2016; 64
Yin, Chen, Wang, Wang, Zhang (CR36) 2017; 23
Chew, Ambrosius, Davis, Danis, Gangaputra, Greven, Hubbard, Esser, Lovato, Perdue, Goff, Cushman, Ginsberg, Elam, Genuth, Gerstein, Schubart, Fine (CR2) 2010; 363
Hotamisligil (CR33) 2006; 444
Wei, Gong, Xu, Duh (CR22) 2016; 99
Park, Kang, Lee, Bae (CR27) 2015; 465
Moran, Wang, Chen, Sapieha, Smith, Ma (CR32) 2016; 311
Rampanelli, Orso, Ochodnicky, Liebisch, Bakker, Claessen, Butter, van den Bergh Weerman, Florquin, Schmitz, Leemans (CR34) 2017; 7
Ruiz, Pergola, Zager, Vaziri (CR7) 2013; 83
Li, Wang, Zhang (CR17) 2011; 286
Li, Wang, Yu, Chen, Mahadev, Zhang (CR15) 2010; 59
Le (CR38) 2017
Loukovaara, Piippo, Kinnunen, Hytti, Kaarniranta, Kauppinen (CR11) 2017
Du, Veenstra, Palczewski, Kern (CR19) 2013; 110
Sorrentino, Allkabes, Salsini, Bonifazzi, Perri (CR31) 2016; 162
Lewis, Fisher (CR18) 2003; 230
Ibarra-Lara, Hong, Soria-Castro, Torres-Narvaez, Perez-Severiano, Del Valle-Mondragon, Cervantes-Perez, Ramirez-Ortega, Pastelin-Hernandez, Sanchez-Mendoza (CR6) 2012; 60
Deng, Han, Yao, Sun, Yu, Cai, Ren, Jiang, Han (CR12) 2017; 42
Cheng, Ding, He, Takahashi, Ma (CR14) 2016; 65
CR21
CR20
Brownlee (CR4) 2005; 54
Chen, Hu, Lin, Jenkins, Keech, Mott, Lyons, Ma (CR29) 2013; 62
Ding, Cheng, Hu, Takahashi, Jenkins, Keech, Humphries, Gu, Elliott, Xia, Ma (CR28) 2014; 184
Ogura, Sutterwala, Flavell (CR9) 2006; 126
Noonan, Jenkins, Ma, Keech, Wang, Lamoureux (CR3) 2013; 62
Chen, Wu, Xu, Kuse, Hara, Duh (CR8) 2017; 154
Xu, Wei, Gong, Cho, Park, Sung, Huang, Wu, Eberhart, Handa, Du, Kern, Thimmulappa, Barber, Biswal, Duh (CR24) 2014; 57
Keech, Mitchell, Summanen, O’Day, Davis, Moffitt, Taskinen, Simes, Tse, Williamson, Merrifield, Laatikainen, d’Emden, Crimet, O’Connell, Colman (CR1) 2007; 370
Wei, Gong, Xu, Thimmulappa, Mitchell, Welsbie, Biswal, Duh (CR23) 2015; 112
Bringmann, Pannicke, Grosche, Francke, Wiedemann, Skatchkov, Osborne, Reichenbach (CR30) 2006; 25
Akiyama, Azuchi, Guo, Noro, Kimura, Harada, Namekata, Harada (CR16) 2017; 58
W Chen (3256_CR35) 2017; 66
S Loukovaara (3256_CR11) 2017
AC Keech (3256_CR1) 2007; 370
WJ Chen (3256_CR8) 2017; 154
Y Deng (3256_CR12) 2017; 42
3256_CR21
3256_CR20
Y Wei (3256_CR23) 2015; 112
Y Yin (3256_CR36) 2017; 23
J Li (3256_CR15) 2010; 59
L Ibarra-Lara (3256_CR6) 2012; 60
JS Park (3256_CR27) 2015; 465
GS Hotamisligil (3256_CR33) 2006; 444
FS Sorrentino (3256_CR31) 2016; 162
Y Du (3256_CR19) 2013; 110
EY Chew (3256_CR2) 2010; 363
K Eastlake (3256_CR37) 2016; 64
L Ding (3256_CR28) 2014; 184
Z Xu (3256_CR24) 2014; 57
E Rampanelli (3256_CR34) 2017; 7
JE Noonan (3256_CR3) 2013; 62
Y Chen (3256_CR29) 2013; 62
M Brownlee (3256_CR4) 2005; 54
Y Sun (3256_CR26) 2016; 11
A Bringmann (3256_CR30) 2006; 25
R Zhou (3256_CR10) 2010; 11
S Ruiz (3256_CR7) 2013; 83
Y Ogura (3256_CR9) 2006; 126
GP Lewis (3256_CR18) 2003; 230
J Li (3256_CR17) 2011; 286
EP Moran (3256_CR32) 2016; 311
G Akiyama (3256_CR16) 2017; 58
Y Wei (3256_CR22) 2016; 99
Y Inoue (3256_CR25) 2017; 141
R Cheng (3256_CR14) 2016; 65
YZ Le (3256_CR38) 2017
Y Zhong (3256_CR13) 2012; 61
Y Cheng (3256_CR5) 2016; 93
References_xml – volume: 112
  start-page: E6927
  year: 2015
  end-page: E6936
  ident: CR23
  article-title: Nrf2 in ischemic neurons promotes retinal vascular regeneration through regulation of semaphorin 6A
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1512683112
– volume: 465
  start-page: 542
  year: 2015
  end-page: 547
  ident: CR27
  article-title: Fenofibrate activates Nrf2 through p62-dependent Keap1 degradation
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2015.08.056
– volume: 62
  start-page: 261
  year: 2013
  end-page: 272
  ident: CR29
  article-title: Therapeutic effects of PPARalpha agonists on diabetic retinopathy in type 1 diabetes models
  publication-title: Diabetes
  doi: 10.2337/db11-0413
– volume: 370
  start-page: 1687
  year: 2007
  end-page: 1697
  ident: CR1
  article-title: Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)61607-9
– volume: 363
  start-page: 233
  year: 2010
  end-page: 244
  ident: CR2
  article-title: Effects of medical therapies on retinopathy progression in type 2 diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1001288
– volume: 110
  start-page: 16586
  year: 2013
  end-page: 16591
  ident: CR19
  article-title: Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1314575110
– volume: 126
  start-page: 659
  year: 2006
  end-page: 662
  ident: CR9
  article-title: The inflammasome: first line of the immune response to cell stress
  publication-title: Cell
  doi: 10.1016/j.cell.2006.08.002
– volume: 93
  start-page: 94
  year: 2016
  end-page: 109
  ident: CR5
  article-title: Up-regulation of Nrf2 is involved in FGF21-mediated fenofibrate protection against type 1 diabetic nephropathy
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2016.02.002
– volume: 83
  start-page: 1029
  year: 2013
  end-page: 1041
  ident: CR7
  article-title: Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease
  publication-title: Kidney Int
  doi: 10.1038/ki.2012.439
– volume: 286
  start-page: 4912
  year: 2011
  end-page: 4921
  ident: CR17
  article-title: Preconditioning with endoplasmic reticulum stress mitigates retinal endothelial inflammation via activation of X-box binding protein 1
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.199729
– volume: 66
  start-page: 157
  year: 2017
  end-page: 166
  ident: CR35
  article-title: Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline
  publication-title: Inflamm Res
  doi: 10.1007/s00011-016-1002-6
– volume: 60
  start-page: 323
  year: 2012
  end-page: 334
  ident: CR6
  article-title: Clofibrate PPARalpha activation reduces oxidative stress and improves ultrastructure and ventricular hemodynamics in no-flow myocardial ischemia
  publication-title: J Cardiovasc Pharmacol
  doi: 10.1097/FJC.0b013e31826216ed
– year: 2017
  ident: CR11
  article-title: NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy
  publication-title: Acta Ophthalmol
  doi: 10.1111/aos.13427
– volume: 230
  start-page: 263
  year: 2003
  end-page: 290
  ident: CR18
  article-title: Up-regulation of glial fibrillary acidic protein in response to retinal injury: its potential role in glial remodeling and a comparison to vimentin expression
  publication-title: Int Rev Cytol
  doi: 10.1016/S0074-7696(03)30005-1
– volume: 444
  start-page: 860
  year: 2006
  end-page: 867
  ident: CR33
  article-title: Inflammation and metabolic disorders
  publication-title: Nature
  doi: 10.1038/nature05485
– volume: 25
  start-page: 397
  year: 2006
  end-page: 424
  ident: CR30
  article-title: Muller cells in the healthy and diseased retina
  publication-title: Prog Retin Eye Res
  doi: 10.1016/j.preteyeres.2006.05.003
– volume: 99
  start-page: 234
  year: 2016
  end-page: 243
  ident: CR22
  article-title: Nrf2 promotes reparative angiogenesis through regulation of NADPH oxidase-2 in oxygen-induced retinopathy
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2016.08.013
– ident: CR21
– volume: 57
  start-page: 204
  year: 2014
  end-page: 213
  ident: CR24
  article-title: NRF2 plays a protective role in diabetic retinopathy in mice
  publication-title: Diabetologia
  doi: 10.1007/s00125-013-3093-8
– volume: 311
  start-page: H738
  year: 2016
  end-page: H749
  ident: CR32
  article-title: Neurovascular cross talk in diabetic retinopathy: pathophysiological roles and therapeutic implications
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00005.2016
– volume: 11
  start-page: 1253
  year: 2016
  end-page: 1258
  ident: CR26
  article-title: Grape seed proanthocyanidin extract protects the retina against early diabetic injury by activating the Nrf2 pathway
  publication-title: Exp Ther Med
  doi: 10.3892/etm.2016.3033
– volume: 141
  start-page: 750
  year: 2017
  end-page: 765
  ident: CR25
  article-title: RS9, a novel Nrf2 activator, attenuates light-induced death of cells of photoreceptor cells and Muller glia cells
  publication-title: J Neurochem
  doi: 10.1111/jnc.14029
– volume: 7
  start-page: 2861
  year: 2017
  ident: CR34
  article-title: Metabolic injury-induced NLRP3 inflammasome activation dampens phospholipid degradation
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-01994-9
– volume: 58
  start-page: 4908
  year: 2017
  end-page: 4914
  ident: CR16
  article-title: Edaravone prevents retinal degeneration in adult mice following optic nerve injury
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.17-22250
– volume: 64
  start-page: 495
  year: 2016
  end-page: 506
  ident: CR37
  article-title: Muller glia as an important source of cytokines and inflammatory factors present in the gliotic retina during proliferative vitreoretinopathy
  publication-title: Glia
  doi: 10.1002/glia.22942
– volume: 154
  start-page: 151
  year: 2017
  end-page: 158
  ident: CR8
  article-title: Nrf2 protects photoreceptor cells from photo-oxidative stress induced by blue light
  publication-title: Exp Eye Res
  doi: 10.1016/j.exer.2016.12.001
– year: 2017
  ident: CR38
  article-title: VEGF production and signaling in Muller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases
  publication-title: Vis Res
  doi: 10.1016/j.visres.2017.05.005
– volume: 61
  start-page: 492
  year: 2012
  end-page: 504
  ident: CR13
  article-title: Activation of endoplasmic reticulum stress by hyperglycemia is essential for Muller cell-derived inflammatory cytokine production in diabetes
  publication-title: Diabetes
  doi: 10.2337/db11-0315
– volume: 65
  start-page: 3730
  year: 2016
  end-page: 3743
  ident: CR14
  article-title: Interaction of PPARalpha with the canonic Wnt pathway in the regulation of renal fibrosis
  publication-title: Diabetes
  doi: 10.2337/db16-0426
– volume: 162
  start-page: 54
  year: 2016
  end-page: 59
  ident: CR31
  article-title: The importance of glial cells in the homeostasis of the retinal microenvironment and their pivotal role in the course of diabetic retinopathy
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2016.08.001
– volume: 62
  start-page: 3968
  year: 2013
  end-page: 3975
  ident: CR3
  article-title: An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes
  publication-title: Diabetes
  doi: 10.2337/db13-0800
– volume: 23
  start-page: 242
  year: 2017
  end-page: 250
  ident: CR36
  article-title: Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-kappaB signaling pathway
  publication-title: Mol Vis
– volume: 11
  start-page: 136
  year: 2010
  end-page: 140
  ident: CR10
  article-title: Thioredoxin-interacting protein links oxidative stress to inflammasome activation
  publication-title: Nat Immunol
  doi: 10.1038/ni.1831
– volume: 59
  start-page: 1528
  year: 2010
  end-page: 1538
  ident: CR15
  article-title: Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4
  publication-title: Diabetes
  doi: 10.2337/db09-1057
– volume: 184
  start-page: 2709
  year: 2014
  end-page: 2720
  ident: CR28
  article-title: Peroxisome proliferator-activated receptor alpha protects capillary pericytes in the retina
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2014.06.021
– volume: 54
  start-page: 1615
  year: 2005
  end-page: 1625
  ident: CR4
  article-title: The pathobiology of diabetic complications: a unifying mechanism
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.6.1615
– volume: 42
  start-page: 2255
  year: 2017
  end-page: 2266
  ident: CR12
  article-title: PPARalpha agonist stimulated angiogenesis by improving endothelial precursor cell function via a NLRP3 inflammasome pathway
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000479999
– ident: CR20
– volume: 65
  start-page: 3730
  year: 2016
  ident: 3256_CR14
  publication-title: Diabetes
  doi: 10.2337/db16-0426
– volume: 141
  start-page: 750
  year: 2017
  ident: 3256_CR25
  publication-title: J Neurochem
  doi: 10.1111/jnc.14029
– volume: 64
  start-page: 495
  year: 2016
  ident: 3256_CR37
  publication-title: Glia
  doi: 10.1002/glia.22942
– ident: 3256_CR21
– volume: 11
  start-page: 136
  year: 2010
  ident: 3256_CR10
  publication-title: Nat Immunol
  doi: 10.1038/ni.1831
– volume: 23
  start-page: 242
  year: 2017
  ident: 3256_CR36
  publication-title: Mol Vis
– volume: 465
  start-page: 542
  year: 2015
  ident: 3256_CR27
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2015.08.056
– volume: 99
  start-page: 234
  year: 2016
  ident: 3256_CR22
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2016.08.013
– ident: 3256_CR20
  doi: 10.1097/00004397-198702740-00004
– volume: 184
  start-page: 2709
  year: 2014
  ident: 3256_CR28
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2014.06.021
– volume: 25
  start-page: 397
  year: 2006
  ident: 3256_CR30
  publication-title: Prog Retin Eye Res
  doi: 10.1016/j.preteyeres.2006.05.003
– volume: 57
  start-page: 204
  year: 2014
  ident: 3256_CR24
  publication-title: Diabetologia
  doi: 10.1007/s00125-013-3093-8
– volume: 62
  start-page: 261
  year: 2013
  ident: 3256_CR29
  publication-title: Diabetes
  doi: 10.2337/db11-0413
– volume: 62
  start-page: 3968
  year: 2013
  ident: 3256_CR3
  publication-title: Diabetes
  doi: 10.2337/db13-0800
– volume: 11
  start-page: 1253
  year: 2016
  ident: 3256_CR26
  publication-title: Exp Ther Med
  doi: 10.3892/etm.2016.3033
– year: 2017
  ident: 3256_CR11
  publication-title: Acta Ophthalmol
  doi: 10.1111/aos.13427
– volume: 58
  start-page: 4908
  year: 2017
  ident: 3256_CR16
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.17-22250
– volume: 112
  start-page: E6927
  year: 2015
  ident: 3256_CR23
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1512683112
– year: 2017
  ident: 3256_CR38
  publication-title: Vis Res
  doi: 10.1016/j.visres.2017.05.005
– volume: 110
  start-page: 16586
  year: 2013
  ident: 3256_CR19
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1314575110
– volume: 154
  start-page: 151
  year: 2017
  ident: 3256_CR8
  publication-title: Exp Eye Res
  doi: 10.1016/j.exer.2016.12.001
– volume: 286
  start-page: 4912
  year: 2011
  ident: 3256_CR17
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.199729
– volume: 230
  start-page: 263
  year: 2003
  ident: 3256_CR18
  publication-title: Int Rev Cytol
  doi: 10.1016/S0074-7696(03)30005-1
– volume: 444
  start-page: 860
  year: 2006
  ident: 3256_CR33
  publication-title: Nature
  doi: 10.1038/nature05485
– volume: 59
  start-page: 1528
  year: 2010
  ident: 3256_CR15
  publication-title: Diabetes
  doi: 10.2337/db09-1057
– volume: 126
  start-page: 659
  year: 2006
  ident: 3256_CR9
  publication-title: Cell
  doi: 10.1016/j.cell.2006.08.002
– volume: 60
  start-page: 323
  year: 2012
  ident: 3256_CR6
  publication-title: J Cardiovasc Pharmacol
  doi: 10.1097/FJC.0b013e31826216ed
– volume: 162
  start-page: 54
  year: 2016
  ident: 3256_CR31
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2016.08.001
– volume: 7
  start-page: 2861
  year: 2017
  ident: 3256_CR34
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-01994-9
– volume: 370
  start-page: 1687
  year: 2007
  ident: 3256_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)61607-9
– volume: 42
  start-page: 2255
  year: 2017
  ident: 3256_CR12
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000479999
– volume: 66
  start-page: 157
  year: 2017
  ident: 3256_CR35
  publication-title: Inflamm Res
  doi: 10.1007/s00011-016-1002-6
– volume: 61
  start-page: 492
  year: 2012
  ident: 3256_CR13
  publication-title: Diabetes
  doi: 10.2337/db11-0315
– volume: 363
  start-page: 233
  year: 2010
  ident: 3256_CR2
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1001288
– volume: 311
  start-page: H738
  year: 2016
  ident: 3256_CR32
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00005.2016
– volume: 54
  start-page: 1615
  year: 2005
  ident: 3256_CR4
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.6.1615
– volume: 93
  start-page: 94
  year: 2016
  ident: 3256_CR5
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2016.02.002
– volume: 83
  start-page: 1029
  year: 2013
  ident: 3256_CR7
  publication-title: Kidney Int
  doi: 10.1038/ki.2012.439
SSID ssj0010011
Score 2.5288985
Snippet Oxidative stress and neuroinflammation contribute significantly to the development and progression of diabetic retinopathy. Fenofibrate has received great...
SourceID proquest
gale
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 105
SubjectTerms Activation
Biochemistry
Biomedical and Life Sciences
Cardiology
Caspase
Caspase-1
Diabetes
Diabetes mellitus
Diabetic retinopathy
Diabetics
Fenofibrate
Fibric acids
Gene expression
Glutamate-ammonia ligase
Glutamine
IL-1β
Inflammasomes
Inflammation
Intercellular adhesion molecule 1
Leakage
Leucine
Life Sciences
Medical Biochemistry
Mice
NRF2 protein
Oncology
Oxidative stress
Pyrin protein
Reactive oxygen species
Retina
Retinopathy
Rodents
Signaling
Streptozocin
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BFgQXHuUVKMhISEigCCdxYueEStWKQxWtKpB6i2zHriq6Sdndou6_ZyZxtt1K9MI5tjXOjGfGnscH8IFnvuGuSOOC0tVEI21spE_jshEeLaxOjO-buB7KqlLHx-U0PLgtQlrlqBN7Rd10lt7Iv-DlmC5URV5-Pf8dE2oURVcDhMZd2KJOZWICW9_2q-nROo5AHs8QR-CxSqQc45p98VzSB4JRS2dIVXy5YZlu6udrBupGxLQ3RAeP_3cLT-BRcEHZ7iAzT-GOa7fh_gBKudqGB3sjBtwz-IVCjNJnqJ8E0zN3RgX96Jyy4cn21DIqgmw7wjVeMbNis67p8cDaE1bNfcooPURTxTvTbcOqw6NpxlCmUQxnetHNcFE74qs9h58H-z_2vscBniG26DYtUTW5RDReSaOFa3imjOPeG4cOkshtqgueWYG3PWvLIpcyk9IooYyyQunEKZu9gEnbte4VMJ1q7aT1zqF7ZrRXrtDc4o-yjcg8dxHwkTW1Db3LCULjrL7qukzcrJGbNXGzvozg03rK-dC447bBH4nfNR1qXNfqUJuA1FF7rHo3p75nBV7_ItjZGIn8sJufR9bXQRks6iu-R_B-_ZlmUoJb67oLGoOKsaS64gheDpK2JjstKQ0xzSP4PIretcX_tafXt5PyBh6i76eGXMYdmCznF-4t3LN_lqeL-btwjv4CuNYjew
  priority: 102
  providerName: ProQuest
Title Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation
URI https://link.springer.com/article/10.1007/s11010-017-3256-x
https://www.ncbi.nlm.nih.gov/pubmed/29264825
https://www.proquest.com/docview/1980713659
https://www.proquest.com/docview/1979494269
Volume 445
WOSCitedRecordID wos000437464800011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: AUTh Library subscriptions: ProQuest Central
  customDbUrl:
  eissn: 1573-4919
  dateEnd: 20181231
  omitProxy: false
  ssIdentifier: ssj0010011
  issn: 0300-8177
  databaseCode: BENPR
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1573-4919
  dateEnd: 20181231
  omitProxy: false
  ssIdentifier: ssj0010011
  issn: 0300-8177
  databaseCode: M7P
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1573-4919
  dateEnd: 20181231
  omitProxy: false
  ssIdentifier: ssj0010011
  issn: 0300-8177
  databaseCode: 7X7
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database
  customDbUrl:
  eissn: 1573-4919
  dateEnd: 20181231
  omitProxy: false
  ssIdentifier: ssj0010011
  issn: 0300-8177
  databaseCode: M2P
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: SpringerLink Journals
  customDbUrl:
  eissn: 1573-4919
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0010011
  issn: 0300-8177
  databaseCode: RSV
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1raxQxcNBWsV98VG231hJBEJSFfWQ32Y-1tPihLsf54L6FJJuUYm-33F3F-_ed2ce1V1TQL4ElkyGPycxk5wXwNkp9Fbk8CXNyV-OVsKERPgmLinuUsDo2vk3ieirKUk4mxaiP454P3u6DSbLl1DfBbnFruEWumiKWEBXHTZR2km7j-Mv3lemAlJzOdBCFMhZiMGX-DsWaMLrLkm_JpDtG0lb2nDz5r1k_hce9qskOO9p4BvdcvQ0Pu-KTy214dDTUensOP5BYkcoM5Y1geuouKHAflVDW_Zo9t4yCHeuG6hcvmVmyaVO1db_qM1bOfMLIDURTZDvTdcXK0_EoZUi7SG5TPW-miNQOddRewLeT469Hn8K-DENoUT1aIAtyMa-8FEZzV0WpNC7y3jhUhHhmE51HqeX4qrO2yDMhUiGM5NJIy6WOnbTpS9iom9rtAtOJ1k5Y7xyqYUZ76XId2TwrbMVTH7kAouE8lO1zlFOpjAt1k12Z9lPhfiraT_UrgPerIZddgo6_Ab-jQ1Z0eRGv1X0MAs6O0mCpw4zym-X4zAtgfw0Sz8Oudw9kovpLP1dxIenNj8sJ4M2qm0aSI1vtmiuCQQZYUPxwADsdea2mnRTkbphkAXwYaOkW8j-tae-foF_BFqp8snNh3IeNxezKvYYH9ufifD47gPtiItpWHsDmx-NyNMavz8mIWkEt3rRrW3Mdcg
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VAioXHoVCoICRQEigiLztHBCqClWrLlGFirQ313bsqqKblN0tdP8Uv5GZPLbdSvTWA-c4lh1_M-PJzHwD8DqIXRnYLPIzSldLSm58zV3k52Xi0MKqULuGxHXAi0IMh_neEvzpa2EorbLXiY2iLmtD_8g_oHNMDlWW5p9OfvrUNYqiq30LjRYWu3b2G122ycedz3i-b6Jo68v-5rbfdRXwDVr7KUqUDZPSCa5VYssgFtoGzmmLdj1JTaSyIDYJOinG5FnKecy5FonQwiRChVaYGOe9ATdRj3NKIePDuYNHdEZhG7UIfBFy3kdRm1K9sAk7o02I8Rv4Zwt28LI1uGAOL8VnG7O3de9_-2D34W53wWYbrUQ8gCVbrcLttuXmbBVWNvsOdw_hB4ooypYmtgymRvaY6Arw6s3aH9JHhlGJZ1VT1-YZ0zM2qsum21l1yIqxixglvyiq52eqKlkx-LYXM5RYFLKRmtQjnNT03eMewfdr2fUaLFd1ZZ8AU5FSlhtnLV4-tXLCZioweDCmTGIXWA-CHgrSdMzs1CDkWJ5zShN6JKJHEnrkmQfv5q-ctLQkVw1-S_iSpLJwXqO6ygtcHZF_yY2UWN0ydG49WF8YiedhFh_3UJOdqpvIc5x58Gr-mN6k9L3K1qc0BtV-TlXTHjxukT1fdpRTkmWUevC-h_qFyf-1p6dXL-UlrGzvfx3IwU6x-wzu4C1XtFmb67A8HZ_a53DL_JoeTcYvGglmcHDdEvAXSAx-0w
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Zb9QwEB6Vcr5wlCtQwEigSqCoOZzYeUCoallRdYlWCKS-BduxUUU3Kbtb6P41fh0zObbdSvStDzzHsez4G89M5vgAXgWxKwObRn5K6Wq8FMbXwkV-VnKHGlaF2jVNXIciz-X-fjZagT99LQylVfZ3YnNRl7Whf-Sb6ByTQ5Um2abr0iJGO4P3Rz99YpCiSGtPp9FCZM_Of6P7Nn23u4Nn_TqKBh--bH_0O4YB36Dmn6F02ZCXTgqtuC2DWGobOKct6niemEilQWw4OizGZGkiRCyEllxqabhUoZUmxnmvwFXBk4Sk61M0WkQwyNZqIxiBL0Mh-ohqU7YXNiFo1A8xfg__ZEknntcMZ1TjuVhtowIHd_7nj3cXbneGN9tqJeUerNhqDa63VJzzNbi53TPf3YcfKLooc5q6aDA1tofUxgBNctb-qD4wjEo_q5rYnOdMz9m4LhsWtOo7yycuYpQUo6jOn6mqZPnw8yhmKMkofGM1rcc4qelZ5R7A10vZ9UNYrerKPgamIqWsMM5aNEq1ctKmKjB4SKbksQusB0EPi8J0HduJOOSwOO01TUgqEEkFIak48eDN4pWjtl3JRYM3CGsFXWU4r1FdRQaujpqCFVsJdXtL0en1YH1pJJ6HWX7cw67orsBpcYo5D14uHtOblNZX2fqYxqA6yKia2oNHLcoXy44ySr6MEg_e9rA_M_m_9vTk4qW8gBsI_GK4m-89hVto_Mo2mXMdVmeTY_sMrplfs4Pp5HkjzAy-XbYA_AUwv4eg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fenofibrate+ameliorates+diabetic+retinopathy+by+modulating+Nrf2+signaling+and+NLRP3+inflammasome+activation&rft.jtitle=Molecular+and+cellular+biochemistry&rft.au=Liu%2C+Qiuping&rft.au=Zhang%2C+Fengjun&rft.au=Zhang%2C+Xian&rft.au=Cheng%2C+Rui&rft.date=2018-08-01&rft.pub=Springer+US&rft.issn=0300-8177&rft.eissn=1573-4919&rft.volume=445&rft.issue=1-2&rft.spage=105&rft.epage=115&rft_id=info:doi/10.1007%2Fs11010-017-3256-x&rft.externalDocID=10_1007_s11010_017_3256_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-8177&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-8177&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-8177&client=summon